Michael Rabinowitz Oramed Pharmaceuticals Inc. (ORMP) insider trading activity

ORMP Quotes by TradingView

Michael Rabinowitz is Chief Commercial Officer of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 109,468 shares of ORMP, which is worth approximately $259,439. The most recent transaction as insider was on Jan 03, 2022, when has been sold 19,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 109K
0% 3M change
0% 12M change
Total Value Held $259,439

Michael Rabinowitz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2022
BUY
Grant, award, or other acquisition
-
19,000 Added 14.79%
109,468 Common Stock
Dec 28 2021
SELL
Payment of exercise price or tax liability
$123,725 $12.98 p/Share
9,532 Reduced 9.53%
90,468 Common Stock
Aug 04 2021
BUY
Grant, award, or other acquisition
-
100,000 Added 50.0%
100,000 Common Stock
MR

Michael Rabinowitz

Chief Commercial Officer
New York,, NY

Track Institutional and Insider Activities on ORMP

Follow ORAMED PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ORMP